Loading...
High Tide Inc.
2LYA.F•XETRA
HealthcareMedical - Pharmaceuticals
€2.06
€0.01(0.74%)
High Tide Inc. (2LYA.F) Financial Performance & Statements
Review High Tide Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
7.10%
↑ 7.10%
Operating Income Growth
112.08%
↑ 112.08%
Net Income Growth
88.97%
↑ 88.97%
Operating Cash Flow Growth
72.04%
↑ 72.04%
Operating Margin
0.42%
↑ 0.42%
Gross Margin
26.45%
↑ 26.45%
Net Profit Margin
-1.27%
↓ 1.27%
ROE
-4.77%
↓ 4.77%
ROIC
1.20%
↑ 1.20%
High Tide Inc. (2LYA.F) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for High Tide Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $138.29M | $131.69M | $124.26M | $128.07M |
| Cost of Revenue | $102.54M | $96.23M | $112.44M | $115.62M |
| Gross Profit | $35.76M | $35.45M | $11.82M | $12.45M |
| Gross Profit Ratio | $0.26 | $0.27 | $0.10 | $0.10 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $26.62M | $25.29M | $8.71M | $8.50M |
| Operating Expenses | $38.59M | $32.40M | $8.71M | $8.50M |
| Total Costs & Expenses | $141.13M | $128.63M | $121.15M | $124.12M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $3.95M | $3.11M | $2.83M | $2.90M |
| Depreciation & Amortization | $5.36M | $5.68M | $7.50M | $6.85M |
| EBITDA | $4.36M | $10.29M | $10.61M | $10.80M |
| EBITDA Ratio | $0.03 | $0.08 | $0.09 | $0.08 |
| Operating Income | -$2.83M | $3.06M | $3.11M | $3.95M |
| Operating Income Ratio | -$0.02 | $0.02 | $0.03 | $0.03 |
| Other Income/Expenses (Net) | -$2.12M | -$1.56M | -$2.69M | -$3.03M |
| Income Before Tax | -$4.96M | $1.50M | -$707000.00 | -$238000.00 |
| Income Before Tax Ratio | -$0.04 | $0.01 | -$0.006 | -$0.002 |
| Income Tax Expense | -$153000.00 | $671000.00 | -$878000.00 | -$233000.00 |
| Net Income | -$4.69M | $717000.00 | -$25000.00 | -$340000.00 |
| Net Income Ratio | -$0.03 | $0.005 | -$0.00 | -$0.003 |
| EPS | -$0.06 | $0.009 | -$0.00 | -$0.004 |
| Diluted EPS | -$0.06 | $0.009 | -$0.00 | -$0.004 |
| Weighted Avg Shares Outstanding | $80.79M | $80.39M | $78.98M | $78.15M |
| Weighted Avg Shares Outstanding (Diluted) | $80.79M | $81.10M | $78.98M | $78.15M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan